This week is almost all about the presidential election, which will resound throughout the stock market -- especially if Donald Trump is elected. Far more studies than not say the markets will tank if Trump surprises most pundits and …
SmarTrend identified an Uptrend for Mylan Nv (NASDAQ:MYL) on September 12th, 2017 at $33.44. In approximately 4 months, Mylan Nv has returned 40.10% as of today's recent price of $46.85. In the past 52 weeks, shares of Mylan Nv …
That amounts to $222.12 a share based on Mylan's closing price Thursday — 10 percent above the price of Perrigo's stock the same day. Perrigo had rejected an earlier proposal of $205 a share, saying it didn't reflect the value of its …
Mylan N.V. MYL is scheduled to report second-quarter 2016 results on Aug 9, after market close. Mylan’s performance has been impressive with the company beating earnings estimates in three of the last four quarters. Overall, the …
Mylan N.V. MYL is scheduled to report first-quarter 2017 results on May 10, before the market opens. The company’s performance has been mixed so far, having beaten earnings estimates in three of the trailing four quarters and missing …
Shareholders of the drugmaker Perrigo have shut the door on a $26-billion hostile takeover bid from Mylan. Mylan said that its cash-and-stock offer failed to garner enough interest from Perrigo shareholders by a Friday morning deadline to …
On Monday, shares of controversy-ridden pharmaceutical company Mylan NV (MYL) are gaining, up over 8.5% in morning trading after the drug maker agreed to pay $465 million in order to settle charges that Mylan overcharged the U.S. …
Mylan NV beat the Street’s expectations and raised its outlook for the year Thursday, and investors merely shrugged. This is the latest illustration of just how high the bar for Mylan has moved higher over the past two weeks — according to …
Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan ... or $232.23 per share in cash and Mylan stock. Perrigo disputed the value of …